UNLABELLED: Few instruments have been developed and validated for the evaluation of multi-dimensional GI symptoms. The Gastrointestinal Symptoms Severity Index (GISSI), a multi-dimensional, self-report instrument, was designed as a brief measure of the frequency, severity, and bothersomeness of individual GI and pelvic floor/urogynecologic symptoms. AIM: To report the psychometric properties of the GISSI subscales, including factorial structure, validity, and internal consistency. METHODS: The GISSI included 32 items that assessed upper and lower GI symptoms and seven items related to pelvic floor/urogynecologic symptoms. A total of 934 patients presenting for upper and lower GI complaints completed the questionnaire between January 2013 and December 2013. The sample was randomly split into derivation (n = 466) and validation datasets (n = 468). A non-patient sample of 200 was collected separately. RESULTS: Exploratory factor analysis supported a six-factor model for the derivation sample that accounted for 69.3 % of the total variance. The six GI symptom clusters were labeled as constipation/difficult defecation (five items), abdominal pain/discomfort (four items), dyspepsia (four items), diarrhea/anal incontinence (four items), GERD/chest symptoms (four items), and nausea/vomiting (two items). Inclusion of additional items related to female pelvic floor/urogynecologic symptoms resulted in a separate factor. Confirmatory factor analysis of the validation dataset supported the a priori hypothesized six-factor measurement model (Χ (2)(428) = 1462.98; P < 0.001; GFI = .88; RMSEA = .051). CONCLUSION: The GISSI demonstrated good to excellent psychometric properties and provided multi-dimensional scaling of prominent GI symptom clusters. Further validation may provide an efficient, valid, and reliable measure of patient-reported clinical outcomes.
UNLABELLED: Few instruments have been developed and validated for the evaluation of multi-dimensional GI symptoms. The Gastrointestinal Symptoms Severity Index (GISSI), a multi-dimensional, self-report instrument, was designed as a brief measure of the frequency, severity, and bothersomeness of individual GI and pelvic floor/urogynecologic symptoms. AIM: To report the psychometric properties of the GISSI subscales, including factorial structure, validity, and internal consistency. METHODS: The GISSI included 32 items that assessed upper and lower GI symptoms and seven items related to pelvic floor/urogynecologic symptoms. A total of 934 patients presenting for upper and lower GI complaints completed the questionnaire between January 2013 and December 2013. The sample was randomly split into derivation (n = 466) and validation datasets (n = 468). A non-patient sample of 200 was collected separately. RESULTS: Exploratory factor analysis supported a six-factor model for the derivation sample that accounted for 69.3 % of the total variance. The six GI symptom clusters were labeled as constipation/difficult defecation (five items), abdominal pain/discomfort (four items), dyspepsia (four items), diarrhea/anal incontinence (four items), GERD/chest symptoms (four items), and nausea/vomiting (two items). Inclusion of additional items related to female pelvic floor/urogynecologic symptoms resulted in a separate factor. Confirmatory factor analysis of the validation dataset supported the a priori hypothesized six-factor measurement model (Χ (2)(428) = 1462.98; P < 0.001; GFI = .88; RMSEA = .051). CONCLUSION: The GISSI demonstrated good to excellent psychometric properties and provided multi-dimensional scaling of prominent GI symptom clusters. Further validation may provide an efficient, valid, and reliable measure of patient-reported clinical outcomes.
Authors: R L Levy; M Von Korff; W E Whitehead; P Stang; K Saunders; P Jhingran; V Barghout; A D Feld Journal: Am J Gastroenterol Date: 2001-11 Impact factor: 10.864
Authors: Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin Journal: Gastroenterology Date: 2002-05 Impact factor: 22.682
Authors: W E Whitehead; M D Crowell; L Bosmajian; A Zonderman; P T Costa; C Benjamin; J C Robinson; B R Heller; M M Schuster Journal: Gastroenterology Date: 1990-02 Impact factor: 22.682
Authors: Nicholas J Talley; Eslie Helen Dennis; V Ann Schettler-Duncan; Brian E Lacy; Kevin W Olden; Michael D Crowell Journal: Am J Gastroenterol Date: 2003-11 Impact factor: 10.864
Authors: Judith McElhiney; Matthew R Lohse; Amindra S Arora; Joanna M Peloquin; Debra M Geno; Melissa M Kuntz; Felicity B Enders; Mary Fredericksen; Adil A Abdalla; Yulia Khan; Nicholas J Talley; Nancy N Diehl; Timothy J Beebe; Ann M Harris; Gianrico Farrugia; Darlene E Graner; Joseph A Murray; G Richard Locke; Rayna M Grothe; Michael D Crowell; Dawn L Francis; April M B Grudell; Tushar Dabade; Angelica Ramirez; MhdMaan Alkhatib; Jeffrey A Alexander; Jessica Kimber; Ganapathy Prasad; Alan R Zinsmeister; Yvonne Romero Journal: Dysphagia Date: 2009-10-24 Impact factor: 3.438
Authors: Brennan M R Spiegel; Ron D Hays; Roger Bolus; Gil Y Melmed; Lin Chang; Cynthia Whitman; Puja P Khanna; Sylvia H Paz; Tonya Hays; Steve Reise; Dinesh Khanna Journal: Am J Gastroenterol Date: 2014-09-09 Impact factor: 10.864
Authors: Brjánn Ljótsson; Michael Jones; Nicholas J Talley; Lars Kjellström; Lars Agréus; Anna Andreasson Journal: United European Gastroenterol J Date: 2020-01-14 Impact factor: 4.623
Authors: Iris Rijnaarts; Nicole M de Roos; Taojun Wang; Erwin G Zoetendal; Jan Top; Marielle Timmer; Koen Hogenelst; Emily P Bouwman; Ben Witteman; Nicole de Wit Journal: J Nutr Sci Date: 2022-04-28